Madecassoside

Madecassoside (Purity ≥80.0%-98.0% HPLC / 100% Water-Soluble / Centella asiatica) | Gold Standard Phyto-Active for Dermal Collagen Remodeling, Wound Re-Epithelialization & Anti-Redness

1. Product Overview & Value Proposition

Madecassoside (羟基积雪草甙 / 羟基积雪草苷), isolated and purified from the herbaceous leaves of Centella asiatica (L.) Urb. (Gotu Kola), represents the undisputed global pharmacological gold standard in topical scar remediation, clinical “Cica” skin-barrier recovery, and connective-tissue extracellular matrix regeneration. Within the complex phytochemistry of Centella asiatica—which comprises triterpenic aglycones (madecassic acid, asiatic acid) and their respective glycosides (madecassoside, asiaticoside)—Madecassoside is structurally unique: it features an additional hydroxyl (-OH) group at the C-6 position of the triterpenoid core, linked at C-28 to an extended trisaccharide chain. This specific stereochemistry imparts remarkable natural water solubility and amphiphilic flexibility, overcoming the severe formulation crystallization and solubility hurdles that notoriously plague poorly soluble triterpenic acids.

In cutaneous wound-healing and dermatological repair biology, Madecassoside acts via selective receptor-mediated gene regulation. It stimulates the phosphorylation of Smad2 and Smad3 downstream of the Transforming Growth Factor-beta (TGF-β) receptor cascade in human dermal fibroblasts. This targeted activation upregulates mRNA and protein synthesis of type I and type III collagen, restores tensile strength across compromised dermal tissue, and speeds keratinocyte migration to accelerate complete epidermal re-epithelialization. Concurrently, Madecassoside is one of the most potent botanical inhibitors of the inflammatory cascade: it blocks nuclear factor kappa B (NF-κB) p65 translocation, downregulates inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and halts the overproduction of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6). By quenching acute vascular dilation, it clears post-inflammatory erythema (PIE), calms sunburn flushing, suppresses burn-induced hyperpigmentation, and halts matrix metalloproteinase-1 (MMP-1) collagen breakdown. Our bulk Madecassoside active delivers versatile manufacturing utility across primary commercial sectors:

• Clinical “Cica” Barrier Repair & Post-Procedure Balms: The essential bioactive core for post-laser, post-microneedling, and post-chemical-peel recovery ointments, accelerating re-epithelialization and closing micro-wounds without stinging.
• Anti-Redness, Rosacea & Reactive Skin Formulations: Suppresses acute neurogenic vasodilation and pro-inflammatory cytokine release, restoring vascular comfort in flush-prone, sensitive, and atopic dermatitis skin types.
• Retinoid & AHA/BHA Buffering Complexes: Co-formulated alongside high-strength resurfacing actives (retinol, retinal, glycolic acid) to buffer chemical irritation, prevent barrier peeling, and maintain deep tissue hydration.
• Oral Nutricosmetics & Joint Connective Tissue Formulations: 100% water-soluble and heat-stable, it acts internally to downregulate joint chondrocyte-degrading enzymes (MMP-13), stimulate collagen remodeling in connective tendons, and reinforce systemic dermal firmness.

As an established bulk Madecassoside manufacturer and direct botanical active supplier, we source mature Centella asiatica foliage from certified GAP agricultural cooperatives, utilizing closed-loop low-temperature hydro-ethanolic extraction, high-efficiency macroporous adsorption chromatography, and multi-stage crystallization. To empower agile skincare brands, formulators, and contract manufacturing organizations (CMOs), we pair uncompromising analytical quality with flexible commercial terms: accessible low MOQ procurement for benchtop pilot trials, multi-ingredient shipment consolidation across our cosmetic bioactives (Ceramide NP, Bakuchiol, Ectoine, L-Ergothioneine, PDRN, Glabridin), and dedicated on-the-ground China-wide raw material sourcing assistance tailored to your exact manufacturing requirements.

2. Product Specifications (Analytical Quality)

3. Functional Applications (Mechanism of Action)

Deploying pharmaceutical-grade Madecassoside across clinical barrier repair creams, post-procedure recovery balms, and anti-redness dermatological cosmetics delivers scientifically verified cellular actions:

• TGF-β/Smad Signaling & Extracellular Matrix Remodeling: Madecassoside selectively activates the phosphorylation of Smad2 and Smad3 transcription factors downstream of the TGF-β type I receptor (TβRI) kinase. This upregulation stimulates human dermal fibroblasts to synthesize type I and type III procollagen, enhances fibronectin expression, and increases hyaluronic acid synthesis, accelerating full structural healing of dermal lesions, mechanical abrasions, and micro-wounds.
• Acceleration of Epidermal Keratinocyte Re-Epithelialization: Promotes the horizontal migration and physiological proliferation of primary human epidermal keratinocytes across denuded basement membranes without triggering abnormal hyperkeratotic scarring. This action rapidly restores continuous epidermal barrier closure following fractional laser resurfacing, chemical peels, and microneedling.
• NF-κB Downregulation & Cytokine Storm Suppression: Physical injury, UV exposure, and barrier disruption trigger the IκB kinase complex to phosphorylate IκBα, releasing nuclear factor kappa B (NF-κB) to translocate into the cell nucleus. Madecassoside directly blocks IκBα phosphorylation and degradation, suppressing the release of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and inducible nitric oxide synthase (iNOS). This halts microvascular hyper-permeability and calms acute inflammatory erythema.
• Matrix Metalloproteinase (MMP-1 & MMP-3) Inhibition: Exposure to solar ultraviolet radiation and cutaneous inflammatory flares triggers AP-1-mediated activation of matrix metalloproteinases. Madecassoside downregulates the catalytic transcription and enzymatic activity of MMP-1 (interstitial collagenase) and MMP-3 (stromelysin-1), shielding newly synthesized and native collagen fibers from enzymatic breakdown.
• Alleviation of Post-Inflammatory Hyperpigmentation (PIH): By suppressing keratinocyte-derived inflammatory mediators (prostaglandin E2 and leukotrienes) that stimulate melanocyte dendrite branching and tyrosinase transcription, Madecassoside prevents post-injury and post-acne pigmentary flares, ensuring clean, even tone restoration across compromised skin.
• Excellent Aqueous Stability Across Cold & Hot Processes: Unlike hydrophobic madecassic acid or asiatic acid, Madecassoside dissolves freely and completely in plain water at room temperature. It remains chemically stable across a broad pH spectrum (pH 4.0 to 7.5) and withstands heating cycles up to 80°C, making it universally compatible with watery toners, hydrogels, sheet masks, and high-internal-phase emulsions.

4. Formulation Combinations & Trending Market Applications

Capitalize on the expanding clinical “Cica” barrier recovery, neuro-dermatology, and medical-aesthetic skincare markets by formulating with our versatile Madecassoside portfolio:

• The Master Clinical “Cica Recovery & Post-Laser Barrier” Balm: Our Madecassoside (≥95%, 0.2%–0.5%) + Ceramide NP (≥98%, 0.2%) + PDRN (Sodium DNA ≥98%, 0.2%) + D-Panthenol (Pro-Vitamin B5, 5.0%) + Plant-Derived Squalane (8.0%) + Zinc Gluconate (0.5%). The globally recognized benchmark medical Cica matrix: Madecassoside drives TGF-β re-epithelialization, Ceramide NP repairs intercellular lamellar bilayers, PDRN fuels nucleotide salvage cellular regeneration, and Panthenol/Zinc provide deep soothing and antimicrobial protection.
• The “Anti-Redness & Neuro-Sensitive Calming” Fluid: Our Madecassoside (≥90%, 0.2%) + Ectoine (≥99.0%, 1.0%–2.0%) + Glabridin (CWS Water-Soluble 10%, 0.5% delivering 0.05% active) + Bisabolol (≥95%, 0.5%) + Multi-Molecular Weight Sodium Hyaluronate (0.5%). A high-tolerance, fragrance-free emulsion engineered to clear post-inflammatory erythema (PIE), extinguish cutaneous burning sensations, and fortify the cellular moisture-shell in rosacea-prone and fragile barrier types.
• The “Retinoid-Buffer & Pro-Collagen” Night Serum: Our Madecassoside (≥90%, 0.2%) + Bakuchiol (≥99.0%, 1.0%) + Niacinamide (≥99.5%, 3.0%) + L-Ergothioneine (≥99.0%, 0.1%) + Palmitoyl Tripeptide-5 (2.0%). A powerful rejuvenating night treatment designed to stimulate collagen synthesis while buffering against retinoid flaking, dry peeling, and micro-inflammatory flares.
• The Oral Nutricosmetic “Joint & Connective Tissue Collagen” Sachet: Our Pure Water-Soluble Madecassoside (≥80%, 50 mg) + Hydrolyzed Marine Collagen Peptides (3,000–5,000 mg) + Boswellia Serrata Extract (AKBA 30%, 100 mg) + Sodium Hyaluronate (Food Grade, 100 mg) + Vitamin C (100 mg). A targeted beauty-from-within drink packet designed to stimulate systemic dermal and articular tendon fibroblast collagen remodeling while inhibiting cartilage-degrading MMP enzymes.

5. Why Choose Us As Your Long-Term Active Ingredient Partner?

• Flexible Low MOQ Policy: Mitigate product launch risk. As an agile low MOQ Madecassoside bulk supplier, our orders start as low as 100 g for ultra-pure clinical grades (≥95%–98%), 500 g for prestige cosmetic grade (≥90%), and 1 kg for standard grade (≥80%), scaling smoothly up to recurring multi-hundred kilogram commercial manufacturing contracts.
• 100% Authentic Centella asiatica Sourcing: Sourced strictly from verified sustainable agricultural plantations of *Centella asiatica*. Every commercial batch is authenticated via HPLC chromatographic fingerprint mapping, certifying authentic botanical origin and complete absence of chemical adulterants or synthetic saponin substitutes.
• Multi-Product Portfolio Consolidation: Streamline your procurement by sourcing your complete barrier recovery and cosmetic active suite (Madecassoside, Ceramide NP, Bakuchiol, Ectoine, L-Ergothioneine, PDRN, Glabridin, Ferulic Acid), longevity vitamins (L-5-MTHF-Ca, β-NMN), and botanical extracts under a single, cost-effective freight shipment to reduce customs overhead and landed freight costs.
• Value-Added China Sourcing Service: In addition to our dedicated *Centella asiatica* extraction facilities and chromatographic purification columns, our on-the-ground technical team audits regional raw leaf harvests, validates HPLC purity testing paperwork, and procures specialized functional ingredients across China tailored to your exact manufacturing roadmap.

6. Quality & Supply Chain Assurance

• GAP-Compliant Centella Leaf Cultivation: Sourced strictly from verified sustainable agricultural cooperatives of *Centella asiatica* (L.) Urb. Leaves are harvested at peak vegetative maturity, ensuring high natural concentrations of madecassoside and asiaticoside while rejecting woody stems, roots, and extraneous dirt.
• Clean Closed-Loop Hydro-Ethanolic Extraction: Manufactured using automated closed-loop aqueous ethanol extraction followed by continuous macroporous resin chromatographic fractionation, membrane nanofiltration, low-temperature vacuum concentration, and recrystallization. Completely free from hazardous petrochemical solvents (such as hexane, chloroform, or benzene) to ensure residual solvents comply with USP <467> and European Cosmetic Regulation limits.
• Validated HPLC Analytical Standardization: Every commercial batch is tested against certified USP and European Pharmacopoeia primary reference standards using High-Performance Liquid Chromatography (HPLC-UV at 205 nm). We quantify pure Madecassoside, monitor secondary triterpenes (asiaticoside, madecassic acid, asiatic acid), and ensure high purity without batch-to-batch variation.
• Spontaneous Water Solubility & Colorless Clarity: Engineered specifically for high-clarity essence lotions, toners, and post-procedure sheet masks: our purified grades dissolve rapidly and completely in room-temperature water (>25 g/L) without cloudiness, precipitation, or sticky residue, maintaining transparent optical clarity (NTU < 2.0).
• Comprehensive ICP-MS & Pesticide Screening: Batch-tested via high-resolution ICP-MS and GC-MS/MS to ensure heavy metals (Lead, Arsenic, Cadmium, Mercury) and agrochemical residues strictly comply with California Prop 65, European Cosmetic Regulation (EC) No 1223/2009, and China Safety and Technical Standards for Cosmetics. Sealed in food/pharma-grade double-polyethylene liners within light-proof aluminum bottles (100 g, 500 g, 1 kg) and heavy-duty 25 kg fiber export drums.

7. FAQ

Q1: What is the biological and chemical difference between Madecassoside, Asiaticoside, and Madecassic Acid?
A1: All three are key active triterpenoids from Centella asiatica, but their molecular structures, solubility, and physiological targets differ:

• Madecassoside (Triterpene Glycoside): The tri-saccharide glycoside of madecassic acid. It possesses high natural water solubility (>25 g/L) and is the most potent constituent for stimulating TGF-β/Smad collagen I and III synthesis, downregulating NF-κB inflammation, and accelerating post-procedure re-epithelialization.
• Asiaticoside (Triterpene Glycoside): The tri-saccharide glycoside of asiatic acid. It specifically promotes type I collagen synthesis and granulation tissue formation in deeper wound-closure phases.
• Madecassic Acid (Free Triterpenic Aglycone): The non-glycosylated free acid. It is practically insoluble in water and must be dissolved in hot oils or glycols; it acts primarily on acute localized anti-inflammatory and burn pathways. Madecassoside is preferred for high-clarity water-based serums and gentle daily formulations.

Q2: Why is Madecassoside the core functional driver in “Cica” skincare products?
A2: “Cica” (derived from Centella asiatica) products were originally developed in clinical dermatology to treat fragile, wounded, or post-operative skin. Madecassoside is the primary scientific engine behind Cica’s clinical reputation: it accelerates keratinocyte migration to close surface barrier wounds, activates fibroblast collagen remodeling, and extinguishes the inflammatory cytokines (IL-1β, TNF-α) that cause stinging, burning, and persistent post-inflammatory redness.

Q3: How do formulators incorporate Madecassoside into cosmetic formulas without solubility issues?
A3: Unlike hydrophobic Centella extracts (such as pure TECA or asiatic acid), high-purity Madecassoside possesses excellent natural water solubility. Formulators can easily incorporate it via:

• Direct Cold-Water Dissolution: Add Madecassoside directly into the water phase at room temperature (20°C–25°C) with moderate stirring; it dissolves into a crystal-clear, transparent solution.
• Emulsion Incorporation: Can be added to the water phase before heating (stable up to 80°C) or pre-dissolved in a small amount of warm water and blended during the cool-down phase (<45°C).
• Formulating Window: Highly stable across a broad pH range of 4.0 to 7.5; compatible with high-molecular-weight polymers (carbomer, xanthan gum, hyaluronic acid) without causing thinning or cloudiness.

Q4: What is the clinically supported usage percentage of Madecassoside in skincare products?
A4: Formulating percentages vary by delivery format and target clinical claim:

• Daily Barrier Soothing Serums & Toners: 0.05% to 0.1% (delivers measurable reductions in skin sensitivity, redness, and TEWL).
• Clinical “Cica” Balms & Post-Laser Recovery Creams: 0.2% to 0.5% (the clinical benchmark dose for accelerated wound closure and collagen synthesis).
• Post-Acne PIH & Dark Mark Treatments: 0.1% to 0.3% (often paired with Niacinamide or Tranexamic Acid).
• Oral Dietary Supplements: 25 mg to 50 mg per day.

Q5: What is the MOQ for bulk Madecassoside orders?
A5: We support agile product commercialization with flexible minimum order quantities starting from just 100 g for ultra-pure clinical grades (≥95%–98%), 500 g for prestige cosmetic grade (≥90%), and 1 kg for standard cosmetic grade (≥80%), scaling smoothly up to recurring multi-hundred kilogram commercial manufacturing contracts.

8. References

1. PubChem: Madecassoside Compound Summary (CID 34540222) – National Center for Biotechnology Information.
2. PubMed Central: Madecassoside: A Comprehensive Review on Its Pharmacological Mechanisms in Wound Healing, Anti-Inflammation, and Dermal Matrix Remodeling – National Institutes of Health research database.

Keywords you may search: bulk Madecassoside supplier, Centella asiatica extract manufacturer, madecassoside 80 90 percent HPLC, pure madecassoside 98 percent powder, Cica barrier repair active raw material, wound healing pentacyclic triterpene, water soluble madecassoside bulk, post inflammatory erythema PIE treatment cosmetic ingredient, low MOQ cosmetic raw material provider, custom China ingredient sourcing service, pure madecassoside bulk